Eyenovia, Inc. (EYEN)


Eyenovia, Inc. (EYEN)

$3.19 USD

0.01 (0.31%)

Updated Jul 19 12:00am

Add EYEN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

EYEN Daily Price Range
EYEN 52-Week Price Range

EYEN News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All EYEN News

Eyenovia, Inc. (EYEN) Company Bio


Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst that has completed Phase III clinical trials for the treatment of chronic angle closure glaucoma; MicroStat that has completed Phase II clinical trials for the treatment of mydriasis; MicroTears for the treatment of dry eye; and MicroPine for the treatment of myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.

EYEN Stock Chart More Charts


EYEN Price/Volume Stats

Current price $3.19
Prev. close $3.18
Day low $3.01
Day high $3.27
50-day MA $4.54
200-day MA $4.39
52-week high $6.98
52-week low $2.40
Volume 167,300
Avg. volume 174,177
Dividend yield N/A
Market Cap 38.45M

EYEN Social Stream


Loading social stream, please wait...

View Full EYEN Social Stream

EYEN Returns

1-mo -27.00%
3-mo -50.39%
6-mo 9.62%
1-year -50.92%
3-year N/A
5-year N/A
YTD 11.93%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A


Page generated in 0.3544 seconds.